🧪 Metformin AMPK Activation Longevity Simulator

AMPK — the Cell's Fuel Gauge

AMPK flips on when cellular energy charge drops.

• AMP:ATP ratio: Sensor type (illustrative energy metric)
• LKB1: Activating kinase (upstream trigger)
• Low activity: Default state (nutrient-rich baseline)
• Metabolic switch: Role (growth vs conservation)

Energy status drives the switch

Rising AMP relative to ATP flips AMPK on.

This stage sets the energy-sensing baseline for later drug activation.

Metformin Turns On AMPK Indirectly

Metformin nudges mitochondria, which nudges AMPK.

• Complex I: Primary target (mild inhibition)
• AMP:ATP ↑: Resulting signal (energy stress mimic)
• AMPK on: Net effect (via LKB1)
• Indirect: Route (not a direct AMPK binder)

A two-step activation chain

Drug to mitochondria to energy shift to AMPK.

Dose strength in the slider scales how strongly this chain fires.

One Switch, Many Metabolic Outputs

Active AMPK radiates signals across metabolism and stress defense.

• Inhibited: mTOR (growth signaling curbed)
• Increased: Autophagy (cellular cleanup)
• Increased: Mitochondrial biogenesis (via PGC-1α)
• Reduced: Inflammation (illustrative trend)

Convergent longevity-associated pathways

Multiple hallmark-of-aging pathways shift together.

Pathway engagement metric aggregates these node activations.

Cohort Studies Hint at a Survival Edge

Observational data show a modest association, not proof.

• Observational: Study type (not randomized)
• Modest: Signal (illustrative association)
• High: Confounding risk (healthy-user bias)
• Not established: Causal proof (pending trials)

Reading the survival curves with caution

Longer use correlates with a gentle survival gap.

This chart is illustrative, not a clinical outcome projection.

From Diabetes Pill to Aging Trial

An old, cheap drug is being tested for a new purpose.

• Type 2 diabetes: Approved use (since 1950s-1990s)
• Well established: Safety record (decades of use)
• TAME (proposed): Key trial (aging as endpoint)
• Investigational: Status (for longevity use)

Why repurposing is attractive

Known safety profile speeds any longevity pathway.

This simulation is illustrative and not medical guidance.